192 related articles for article (PubMed ID: 32360900)
1. Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.
Zhang H; Zhang Y; Terajima M; Romanowicz G; Liu Y; Omi M; Bigelow E; Joiner DM; Waldorff EI; Zhu P; Raghavan M; Lynch M; Kamiya N; Zhang R; Jepsen KJ; Goldstein S; Morris MD; Yamauchi M; Kohn DH; Mishina Y
Bone; 2020 Aug; 137():115402. PubMed ID: 32360900
[TBL] [Abstract][Full Text] [Related]
2. Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.
Zhang Y; McNerny EG; Terajima M; Raghavan M; Romanowicz G; Zhang Z; Zhang H; Kamiya N; Tantillo M; Zhu P; Scott GJ; Ray MK; Lynch M; Ma PX; Morris MD; Yamauchi M; Kohn DH; Mishina Y
Bone; 2016 Jul; 88():74-84. PubMed ID: 27113526
[TBL] [Abstract][Full Text] [Related]
3. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
[TBL] [Abstract][Full Text] [Related]
4. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
[TBL] [Abstract][Full Text] [Related]
5. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.
Shi C; Iura A; Terajima M; Liu F; Lyons K; Pan H; Zhang H; Yamauchi M; Mishina Y; Sun H
Sci Rep; 2016 Apr; 6():24256. PubMed ID: 27048979
[TBL] [Abstract][Full Text] [Related]
6. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein signaling through ACVR1 and BMPR1A negatively regulates bone mass along with alterations in bone composition.
Shi C; Mandair GS; Zhang H; Vanrenterghem GG; Ridella R; Takahashi A; Zhang Y; Kohn DH; Morris MD; Mishina Y; Sun H
J Struct Biol; 2018 Mar; 201(3):237-246. PubMed ID: 29175363
[TBL] [Abstract][Full Text] [Related]
8. Mechanical Loading Synergistically Increases Trabecular Bone Volume and Improves Mechanical Properties in the Mouse when BMP Signaling Is Specifically Ablated in Osteoblasts.
Iura A; McNerny EG; Zhang Y; Kamiya N; Tantillo M; Lynch M; Kohn DH; Mishina Y
PLoS One; 2015; 10(10):e0141345. PubMed ID: 26489086
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
10. Increased BMP-Smad signaling does not affect net bone mass in long bones.
Omi M; Koneru T; Lyu Y; Haraguchi A; Kamiya N; Mishina Y
Front Physiol; 2023; 14():1145763. PubMed ID: 37064883
[TBL] [Abstract][Full Text] [Related]
11. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.
Baud'huin M; Solban N; Cornwall-Brady M; Sako D; Kawamoto Y; Liharska K; Lath D; Bouxsein ML; Underwood KW; Ucran J; Kumar R; Pobre E; Grinberg A; Seehra J; Canalis E; Pearsall RS; Croucher PI
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12207-12. PubMed ID: 22761317
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
13. BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells.
Biswas S; Li P; Wu H; Shafiquzzaman M; Murakami S; Schneider MD; Mishina Y; Li B; Li J
Sci Rep; 2018 May; 8(1):8475. PubMed ID: 29855498
[TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
15. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.
Pan H; Zhang H; Abraham P; Komatsu Y; Lyons K; Kaartinen V; Mishina Y
Dev Biol; 2017 Sep; 429(1):260-270. PubMed ID: 28641928
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.
Mishina Y; Starbuck MW; Gentile MA; Fukuda T; Kasparcova V; Seedor JG; Hanks MC; Amling M; Pinero GJ; Harada S; Behringer RR
J Biol Chem; 2004 Jun; 279(26):27560-6. PubMed ID: 15090551
[TBL] [Abstract][Full Text] [Related]
17. Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse.
Lim J; Shi Y; Karner CM; Lee SY; Lee WC; He G; Long F
Development; 2016 Jan; 143(2):339-47. PubMed ID: 26657771
[TBL] [Abstract][Full Text] [Related]
18. BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.
Shi C; Zhang H; Louie K; Mishina Y; Sun H
J Cell Biochem; 2017 Mar; 118(3):605-614. PubMed ID: 27649478
[TBL] [Abstract][Full Text] [Related]
19. Disruption of bone morphogenetic protein type IA receptor in osteoblasts impairs bone quality and bone strength in mice.
Bao Q; Li A; Chen S; Feng J; Liu H; Qin H; Li J; Liu D; Shen Y; Zong Z
Cell Tissue Res; 2018 Nov; 374(2):263-273. PubMed ID: 29987355
[TBL] [Abstract][Full Text] [Related]
20. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
Choi HY; Dieckmann M; Herz J; Niemeier A
PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
